Arbutus Biopharma (ABUS) Goodwill (2015 - 2019)

Arbutus Biopharma has disclosed Goodwill across 5 years of filings, most recently posting $22.5 million for Q2 2019.

• Goodwill for Q2 2019 came in at $22.5 million, changed 0.0% year-over-year; the trailing twelve-month figure through Jun 2019 was $22.5 million (changed 0.0% YoY), and the FY2018 annual result was $22.5 million, down 7.77% from the prior year.
• Goodwill came in at $22.5 million for Q2 2019 at Arbutus Biopharma, roughly flat from $22.5 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $162.5 million in Q4 2015 to a low of $22.5 million in Q2 2018.
• The 5-year median for Goodwill is $24.4 million (2016), against an average of $76.5 million.
• Peak annual rise in Goodwill reached 4.27% in 2016, while the deepest fall reached 85.01% in 2016.
• Arbutus Biopharma's Goodwill stood at $162.5 million in 2015, then slumped by 85.01% to $24.4 million in 2016, then changed by 0.0% to $24.4 million in 2017, then retreated by 7.77% to $22.5 million in 2018, then changed by 0.0% to $22.5 million in 2019.
• The last three Goodwill figures came in at $22.5 million (Q2 2019), $22.5 million (Q1 2019), and $22.5 million (Q4 2018), per Business Quant data.